Find a Trial

Trial Summary


Protocol No.PHO-NOVARTISMAPS-SKILES
StatusOPEN TO ACCRUAL
Principal InvestigatorSkiles, Jodi
ScopeNational
PhaseNA
Age GroupAdults and Children
TitleManaged Access Program (MAP) to provide access to CTL019, for acute lymphoblastic leukemia (ALL) or diffuse large b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial release
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
    Treatment TypeTreatment
    ContactCourtney B. Spiegel, Phone: +1 317-948-0581
    Pager:
    Email: clorch@iu.edu